Spore.Bio was established in 2023 by ex-Nestlé employee Amine Raji, Maxime Mistretta, and Mohamed Tazi, previously the founder of Gymlib. Despite the promising technology and recent funding, the company faces competition from US-based PathogenDX, which has raised $11.6 million for its own solutions.
Key takeaways:
- Spore.Bio, a French startup, has developed a pathogen detection device that uses optical light to detect harmful microbes on food processing factory surfaces.
- The device compares the detected microbes with its training data, which is faster than sending tests to a lab. The startup claims its solution works almost in real time, compared to the 5-20 days factoring testing normally takes.
- Spore.Bio has raised €8 million in pre-seed funding from various investors including London’s LocalGlobe VC, EmergingTech Ventures, No Label Ventures, and others.
- The company, founded in 2023, faces competition from US-based PathogenDX, which has raised $11.6M for its various other solutions.